Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase.

Yanase M, Ikeda H, Matsui A, Maekawa H, Noiri E, Tomiya T, Arai M, Yano T, Shibata M, Ikebe M, Fujiwara K, Rojkind M, Ogata I.

Biochem Biophys Res Commun. 2000 Oct 14;277(1):72-8.

PMID:
11027642
2.

Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.

Sawada K, Morishige Ki, Tahara M, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y.

Gynecol Oncol. 2002 Dec;87(3):252-9.

PMID:
12468322
3.

A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth.

Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H.

J Hepatol. 2000 May;32(5):762-70.

PMID:
10845663
5.
6.

Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction.

van Nieuw Amerongen GP, Vermeer MA, van Hinsbergh VW.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):E127-33.

7.

Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells.

Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S, Fujiwara K.

Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G880-6. Epub 2003 Jun 26.

8.

Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.

Iizuka M, Murata T, Hori M, Ozaki H.

Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1010-21. doi: 10.1152/ajpgi.00350.2010. Epub 2011 Mar 10.

9.

Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.

Rao PV, Deng PF, Kumar J, Epstein DL.

Invest Ophthalmol Vis Sci. 2001 Apr;42(5):1029-37. Erratum in: Invest Ophthalmol Vis Sci 2001 Jul;42(8):1690.

PMID:
11274082
10.

Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line.

Yanase M, Ikeda H, Ogata I, Matsui A, Noiri E, Tomiya T, Arai M, Inoue Y, Tejima K, Nagashima K, Nishikawa T, Shibata M, Ikebe M, Rojkind M, Fujiwara K.

Biochem Biophys Res Commun. 2003 May 30;305(2):223-8.

PMID:
12745062
11.

Oxytocin and lysophosphatidic acid induce stress fiber formation in human myometrial cells via a pathway involving Rho-kinase.

Gogarten W, Emala CW, Lindeman KS, Hirshman CA.

Biol Reprod. 2001 Aug;65(2):401-6.

PMID:
11466206
12.

Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis.

Cho MK, Lee GH, Park EY, Kim SG.

Tissue Cell. 2004 Oct;36(5):293-305.

PMID:
15385147
13.
14.
15.

Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.

Takeda H, Matozaki T, Fujioka Y, Takada T, Noguchi T, Yamao T, Tsuda M, Ochi F, Fukunaga K, Narumiya S, Yamamoto T, Kasuga M.

Oncogene. 1998 Jun 11;16(23):3019-27.

16.

Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase.

Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K.

Science. 1997 Feb 28;275(5304):1308-11.

17.

Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.

Izawa I, Amano M, Chihara K, Yamamoto T, Kaibuchi K.

Oncogene. 1998 Dec 3;17(22):2863-71.

18.

ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1.

Kawada N, Seki S, Kuroki T, Kaneda K.

Biochem Biophys Res Commun. 1999 Dec 20;266(2):296-300.

PMID:
10600496
19.

Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways.

Ai S, Kuzuya M, Koike T, Asai T, Kanda S, Maeda K, Shibata T, Iguchi A.

Atherosclerosis. 2001 Apr;155(2):321-7.

PMID:
11254902
20.

Sustained tyrosine-phosphorylation of FAK through Rho-dependent adhesion to fibronectin is essential for cancer cell migration.

Mukai M, Togawa A, Imamura F, Iwasaki T, Ayaki M, Mammoto T, Nakamura H, Tatsuta M, Inoue M.

Anticancer Res. 2002 Nov-Dec;22(6A):3175-84.

PMID:
12530062

Supplemental Content

Support Center